News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Genetic markers being used to target oral hepatitis C drug

Please note embargo:

Pharmac_P540c

Genetic markers being used to target new oral hepatitis C drug

A person’s genetic makeup will be used to target a new funded oral treatment for hepatitis C patients from 1 September.

PHARMAC will begin funding boceprevir (Victrelis) from 1 September 2013 for certain patients with the chronic liver infection. Boceprevir will be funded when used as a triple therapy in combination with pegylated interferon with ribavirin.

PHARMAC Medical Director Dr Peter Moodie says many hepatitis C patients do not respond well to current treatments, but that this could improve with the addition of boceprevir.

“Clinical evidence shows that, given the genetic characteristics of a patient, a simple genetic test can fairly accurately predict how they might respond to treatment,” says Dr Moodie.

“There is a group who we know respond poorly to current treatment. They are the ones we think will benefit most from the addition of this new treatment.”

About 25-35% of patients with certain genes showed a sustained response to the currently available treatment of pegylated interferon and ribavirin. By adding boceprevir to the treatment of these patients, the response rate increases to 70–75%.

As well as adding greater effectiveness to available treatments, Dr Moodie says boceprevir is the first funded oral treatment specifically for hepatitis C.

Patients will be genetically tested to determine whether they qualify for boceprevir (in combination with pegylated interferon and ribavirin) as a first-line treatment.

Boceprevir will also be funded for people who have tried but not responded completely to a course of pegylated interferon and ribavirin.

Dr Moodie says though many people live with hepatitis C without ever knowing it, the infection can cause significant health issues including hepatocellular carcinoma, liver failure, which may require a liver transplant.

Pharmacological treatment aims to reduce the likelihood of these transplants being required. In total, PHARMAC expects around 300 patients to start triple therapy in the next year.

In addition to funding boceprevir, PHARMAC has negotiated a price reduction for the Pegasys brand of pegylated interferon with ribavirin. Together, the funding of these hepatitis C treatments will cost $17.8 million over five years, with some of this cost being refunded through confidential rebates negotiated with both suppliers.

ENDS


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Review: Henry Rollins Burning Down The House

With his lantern jaw, close-cropped hair, and muscle-bound physique, Henry Rollins could not be further from the US Marine image his appearance might suggest. More>>

A Series Of Tubes: 150 Years Of The Cook Strait Cable

“It was a momentous achievement for its time. The successful connection came on the third attempt at laying the cable, and followed a near disaster when the first cable snapped - almost destroying the ship Weymouth in the process,” says Ms Adams. More>>

ALSO:

February 2017: Guns N' Roses - New Zealand Dates Announced

Founder Axl Rose and former members, Slash and Duff McKagan have regrouped for one of the century’s most anticipated tours... Rolling Stone said: "This was the real thing, the thing we'd all been waiting for: the triumphant return of one of the most important bands to cross rock music history. And it happened in our lifetime.” More>>

Werewolf: Brando, Peckinpah And Billy The Kid

Gordon Campbell: Initially, One-Eyed Jacks was supposed to have been directed by Stanley Kubrick from a script by Sam Peckinpah – yet it quickly became Brando’s baby... More>>

Book Awards: ANZAC Heroes Wins Margaret Mahy Book Of The Year

“Simply stunning, with gold-standard production values,” say the judges of the winner of this year’s Margaret Mahy Book of the Year Award in the prestigious New Zealand Book Awards for Children and Young Adults. ANZAC Heroes is also the winner of the Elsie Locke Award for the Best Book in the Non-Fiction category. More>>

Baby Animals: Hamilton Zoo Rhino Calf Named

Hamilton Zoo’s latest rhino calf has been named Samburu and he's being celebrated with a unique zoo experience... Samburu arrived after his mother Kito’s 16-month pregnancy and the calf brings the number of white rhinos at Hamilton Zoo to six. More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news